← All companies
BIOB
Bio-Rad Laboratories, Inc.
$337.00
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$9.04B
Revenue (TTM)
$2.59B
Net income (TTM)
$222M
EPS (TTM)
$8.19
P/E ratio
41.1
Dividend yield
—
Free cash flow
$375M
Cash
$517M
Total assets
$10.3B
Gross margin
51.9%
52-week range
$244.54 – $337.00
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Aug 4, 2026
8-K
Results of operations (earnings release); Exit or disposal costs; Regulation FD disclosure
Aug 4, 2026
10-Q
Quarter ended 2026-03-31
Apr 30, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Apr 30, 2026
8-K
Director or officer change; Shareholder vote results
Apr 24, 2026
8-K
Regulation FD disclosure
Feb 19, 2026
10-K
Fiscal year ended 2025-12-31
Feb 13, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 12, 2026
10-Q
Quarter ended 2025-09-30
Oct 29, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Oct 29, 2025
8-K
Regulation FD disclosure
Sep 30, 2025
8-K
Regulation FD disclosure
Aug 26, 2025
10-Q
Quarter ended 2025-06-30
Jul 31, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jul 31, 2025
8-K
Director or officer change; Other events
Jul 28, 2025
8-K
Other events
Jun 30, 2025
10-Q
Quarter ended 2025-03-31
May 1, 2025
8-K
Results of operations (earnings release)
May 1, 2025
8-K
Shareholder vote results
Apr 25, 2025
8-K
Regulation FD disclosure
Feb 21, 2025
10-K
Fiscal year ended 2024-12-31
Feb 14, 2025
8-K
Results of operations (earnings release); Exit or disposal costs; Other events
Feb 13, 2025
10-Q
Quarter ended 2024-09-30
Oct 31, 2024
8-K
Results of operations (earnings release)
Oct 30, 2024
8-K
Amended charter or bylaws
Sep 9, 2024
8-K
Director or officer change
Aug 20, 2024
10-Q
Quarter ended 2024-06-30
Aug 2, 2024
8-K
Results of operations (earnings release); Other events
Aug 1, 2024
10-Q
Quarter ended 2024-03-31
May 8, 2024
8-K
Results of operations (earnings release)
May 7, 2024
8-K
Director or officer change; Shareholder vote results; Regulation FD disclosure
Apr 26, 2024
8-K
Director or officer change
Apr 10, 2024
8-K
Director or officer change
Mar 20, 2024
8-K
Regulation FD disclosure
Feb 21, 2024
10-K
Fiscal year ended 2023-12-31
Feb 16, 2024
8-K
Results of operations (earnings release)
Feb 15, 2024
8-K
Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Director or officer change
Feb 14, 2024
8-K
Director or officer change
Dec 7, 2023
10-Q
Quarter ended 2023-09-30
Oct 27, 2023
8-K
Results of operations (earnings release)
Oct 26, 2023